PortfoliosLab logoPortfoliosLab logo
BBC vs. DBE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BBC vs. DBE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Invesco DB Energy Fund (DBE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BBC achieves a 8.64% return, which is significantly lower than DBE's 83.68% return. Over the past 10 years, BBC has underperformed DBE with an annualized return of 7.64%, while DBE has yielded a comparatively higher 12.03% annualized return.


BBC

1D
0.43%
1M
-6.52%
YTD
8.64%
6M
14.08%
1Y
116.78%
3Y*
19.99%
5Y*
-1.96%
10Y*
7.64%

DBE

1D
2.33%
1M
-5.45%
YTD
83.68%
6M
74.95%
1Y
84.41%
3Y*
23.42%
5Y*
19.66%
10Y*
12.03%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BBC vs. DBE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BBC
Virtus LifeSci Biotech Clinical Trials ETF
8.64%63.77%-1.11%-1.80%-35.13%-22.31%30.32%63.81%-18.29%57.85%
DBE
Invesco DB Energy Fund
83.68%-2.17%2.96%-12.14%33.77%57.56%-25.91%19.72%-12.95%5.21%

Correlation

The correlation between BBC and DBE is -0.23, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.23

Correlation (3Y)
Calculated over the trailing 3-year period

-0.09

Correlation (5Y)
Calculated over the trailing 5-year period

-0.01

Correlation (10Y)
Calculated over the trailing 10-year period

0.09

Correlation (All Time)
Calculated using the full available price history since Dec 18, 2014

0.09

The correlation between BBC and DBE shifts across timeframes, from -0.23 (1 year) to 0.09 (10 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BBC vs. DBE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBC
BBC Risk / Return Rank: 8989
Overall Rank
BBC Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
BBC Sortino Ratio Rank: 8787
Sortino Ratio Rank
BBC Omega Ratio Rank: 7777
Omega Ratio Rank
BBC Calmar Ratio Rank: 9595
Calmar Ratio Rank
BBC Martin Ratio Rank: 9393
Martin Ratio Rank

DBE
DBE Risk / Return Rank: 7171
Overall Rank
DBE Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
DBE Sortino Ratio Rank: 6363
Sortino Ratio Rank
DBE Omega Ratio Rank: 6565
Omega Ratio Rank
DBE Calmar Ratio Rank: 9191
Calmar Ratio Rank
DBE Martin Ratio Rank: 6363
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBC vs. DBE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Invesco DB Energy Fund (DBE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BBCDBEDifference
Sharpe ratioReturn per unit of total volatility

+0.89

Sortino ratioReturn per unit of downside risk

+1.02

Omega ratioGain probability vs. loss probability

1.46

1.40

+0.06

Calmar ratioReturn relative to maximum drawdown

7.78

5.89

+1.89

Martin ratioReturn relative to average drawdown

24.80

11.53

+13.27

BBC vs. DBE - Sharpe Ratio Comparison

The current BBC Sharpe Ratio is 3.32, which is higher than the DBE Sharpe Ratio of 2.43. The chart below compares the historical Sharpe Ratios of BBC and DBE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


BBCDBEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

3.32

2.43

+0.89

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.05

0.67

-0.72

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.20

0.43

-0.22

Sharpe Ratio (All Time)

Calculated using the full available price history

0.12

0.09

+0.02

Drawdowns

BBC vs. DBE - Drawdown Comparison

The maximum BBC drawdown since its inception was -76.85%, smaller than the maximum DBE drawdown of -86.69%. Use the drawdown chart below to compare losses from any high point for BBC and DBE.


Loading charts...

Drawdown Indicators


BBCDBEDifference

Max Drawdown

Largest peak-to-trough decline

-76.85%

-86.69%

+9.84%

Max Drawdown (1Y)

Largest decline over 1 year

-15.10%

-14.41%

-0.69%

Max Drawdown (3Y)

Largest decline over 3 years

-54.45%

-23.89%

-30.56%

Max Drawdown (5Y)

Largest decline over 5 years

-72.44%

-38.74%

-33.70%

Max Drawdown (10Y)

Largest decline over 10 years

-76.85%

-60.84%

-16.01%

Current Drawdown

Current decline from peak

-30.27%

-30.27%

0.00%

Average Drawdown

Average peak-to-trough decline

-37.14%

-57.31%

+20.17%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.73%

7.35%

-2.62%

Volatility

BBC vs. DBE - Volatility Comparison

The current volatility for Virtus LifeSci Biotech Clinical Trials ETF (BBC) is 10.93%, while Invesco DB Energy Fund (DBE) has a volatility of 12.95%. This indicates that BBC experiences smaller price fluctuations and is considered to be less risky than DBE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BBCDBEDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.93%

12.95%

-2.02%

Volatility (6M)

Calculated over the trailing 6-month period

26.43%

30.86%

-4.43%

Volatility (1Y)

Calculated over the trailing 1-year period

35.50%

34.97%

+0.53%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

39.31%

29.39%

+9.92%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

37.74%

28.33%

+9.41%

BBC vs. DBE - Expense Ratio Comparison

BBC has a 0.79% expense ratio, which is higher than DBE's 0.78% expense ratio.


Dividends

BBC vs. DBE - Dividend Comparison

BBC's dividend yield for the trailing twelve months is around 1.56%, less than DBE's 2.10% yield.


PositionTTM20252024202320222021202020192018201720162015
BBC
Virtus LifeSci Biotech Clinical Trials ETF
1.56%1.70%1.00%0.34%0.00%0.00%0.00%0.00%0.00%2.09%0.00%0.51%
DBE
Invesco DB Energy Fund
2.10%3.86%6.32%3.87%0.75%0.00%0.00%1.79%1.67%0.00%0.00%0.00%

Frequently Asked Questions


BBC and DBE have a correlation of -0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

DBE has higher volatility (12.95%) compared to BBC (10.93%). In terms of maximum drawdown, BBC dropped -76.85% vs DBE's -86.69%.

On 10-year performance, DBE leads with 12.03% vs 7.64% for BBC. On fees, DBE is cheaper at 0.78% per year. On volatility, BBC has been the lower-risk option at 10.93%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, DBE has performed better with a 12.03% return vs 7.64%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

DBE is cheaper with a 0.78% expense ratio, compared with 0.79% for BBC.

DBE has the higher dividend yield at 2.10%, compared with 1.56% for BBC.

BBC is categorized as Health & Biotech Equities, while DBE is Oil & Gas. BBC tracks LifeSci Biotechnology Clinical Trials Index, while DBE tracks DBIQ Optimum Yield Energy Index. They also come from different issuers: Virtus Investment Partners and Invesco. Their fees differ too: 0.79% for BBC and 0.78% for DBE.

BBC currently has the higher Sharpe Ratio (3.32 vs 2.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BBC and DBE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer